{"schema_version":"secwatch.filing_event.v1","accession":"0001604665-22-000033","form_type":"8-K","ticker":"WLKP","cik":"0001604665","company_name":"Westlake Chemical Partners LP","filed_at":"2022-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.380694+00:00","generated_at":"2026-06-22T09:06:04.803774+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Westlake Chemical Partners Q3 net income up 16% to $14.8M; declares $0.4714 distribution","bullets":["Net income attributable to Partnership $14.8M ($0.42/unit) vs $12.8M in Q3 2021, up 16%.","Declared Q3 distribution $0.4714/unit payable Nov 28 to holders of record Nov 10; 33rd consecutive.","Cash from ops $115.5M, up $16M YoY; MLP distributable cash flow $16.7M, coverage ratio 1.07x trailing twelve months.","Received $13.9M buyer deficiency fee from Westlake due to volatile downstream demand lowering planned offtake.","CEO cites ratable sales agreement with Westlake providing fixed margin on 95% of production, optimistic for 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001604665-22-000033","json":"https://secwatch.observer/filing/0001604665-22-000033.json","markdown":"https://secwatch.observer/filing/0001604665-22-000033.md","text":"https://secwatch.observer/filing/0001604665-22-000033.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1604665/000160466522000033/0001604665-22-000033-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1604665/000160466522000033/wlkp-20221103.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T09:06:04.803774+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"568296ccff742f8573d78ab5b9f21f36cd0143a5","claim":"Westlake Chemical Partners LP reported the third quarter of 2022 results: net income $14.8 million, EPS $0.42 per limited partner unit.","evidence_excerpt":"Westlake Chemical Partners LP (NYSE: WLKP) (the \"Partnership\") today reported net income attributable to the Partnership in the third quarter of 2022 of $14.8 million, or $0.42 per limited partner unit, an increase of $2.0 million compared to third quarter 2021 of $12.8 million.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1604665/000160466522000033/0001604665-22-000033-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the third quarter of 2022"},{"label":"Net income","value":"$14.8 million"},{"label":"EPS","value":"$0.42 per limited partner unit"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}